Sitemap

Statement on COVID-19

23rd Mar 2020

Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we are

First transdermal patch to treat schizophrenia hits market

18th Mar 2020

The US Food and Drug Administration (FDA) has officially approved a transdermal patch to treat schizophrenia

Richmond Pharmacology supporting clinical facilities in Nicaragua

30th Jan 2020

Richmond Pharmacology have developed a resourceful way to use study equipment to help reduce waste produced on site

Cardiac Safety London

To help to enrich and speeding up your drug development programs, join us for a day of discovery as global experts